未来属于相信多重 CAR-T 工程的人
The future belongs to those who believe in multiplex CAR T engineering.
肿瘤细胞治疗研究
ALL SOURCES
把在研试验和前沿论文合在一起看,按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和(导航里的「临床试验」板块只收在招的那部分,不另计入)。
The future belongs to those who believe in multiplex CAR T engineering.
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。